✔️#AFIJI Cohort 20 year-follow-up: fal.cn/34s2J @ActionCoeur
✔️ Editorial: fal.cn/34s2K by @ErinMichos and @AChoiHeart
Arora, et al @CircAHA: fal.cn/34s2N
1⃣: Evaluate the rate of first recurrent MACE and associated risk factors
2⃣: Determine the relationship b/w the initial lesion and the new lesions
3⃣: Determine the rate of repeated recurrences
✔️Recurrence rates high despite medical Rx
✔️Recurrent events generally occurred from new coronary lesions (non-obstructive plaques that progressed)
✔️48% with 1st recurrence not taking high-intensity statin
fal.cn/34s3H
✔️Factors associated w recurrence: insufficient control of conventional risk factors, multivessel disease, Sub-Saharan African ethnicity & inflammatory disease.
🚬Smoking was strongest modifiable risk factor
fal.cn/34s3H
✔️Team-based and pt-centered to better implant guideline care
✔️Consider ezetimibe if LDL > 70 despite max statin
✔️Direct efforts to #cvPrev as per @ACCinTouch /@American_Heart 2019 guidelines. fal.cn/34s3V